Preventing recurrent UTIs
Vaccines and non-antibiotic prevention of recurrent urinary tract infections.
Papers per year
Each bar is 12 months; the last one ends 17 Oct 2026. New trials in the same years: 23, 19, 19, 30, 31.
All papers from the last 12 months
125 papers (18 Oct 2025 – 17 Oct 2026), newest first. Loading the full list…
- Preventive strategies for recurrent urinary tract infections in premenopausal women: A scoping reviewEur J Gen Pract2026 DecPMID 42132404
- Vaginal Estrogen Application Techniques for Prevention of Urinary Tract Infection: A Randomized TrialObstet Gynecol2026 Nov 1PMID 42492951RCT
- Digital health technologies for the prevention and management of urinary tract infections in menopausal women: A systematic reviewMaturitas2026 Oct 7PMID 42863282Review
- Sex as a Trigger, Avoidance as the Consequence: Characterizing Post-Coital Recurrent UTI in WomenUrol Int2026 Oct 5PMID 42832463
- Preclinical Evaluation of Bacterial Lysates in Murine Disease Models: A Systematic ReviewImmun Inflamm Dis2026 OctPMID 42878288Systematic reviewReview
- Women's Experiences of Recurrent UTIs: A Qualitative Study of Preventive Management and Decision Support NeedsHealth Expect2026 OctPMID 42828512
- Exploring precision risk in pediatric vesicoureteral reflux: Innate immune gene variations and reflux outcomes in the RIVUR cohortJ Pediatr Urol2026 OctPMID 42302586
- The future of pediatric vesicoureteral reflux managementJ Pediatr Urol2026 OctPMID 42265024Review
- Escherichia coli Nissle 1917 for the prevention of recurrent uncomplicated urinary tract infections in women: a pilot randomized placebo-controlled trialArch Ital Urol Androl2026 Sep 25PMID 42803671RCT
- Targeted lysosomal activation in bladder epithelium enhances clearance of intracellular uropathogenic Escherichia coliPLoS Pathog2026 SepPMID 42789533
More urology trends
All specialties →PSMA PET in prostate cancer
PSMA PET imaging for staging and recurrence of prostate cancer.
Key point: PSMA-PET/CT is recommended only when PSA exceeds 0.2 μg/L, reporting should follow PSMA-RADS, and it is preferred over lymph-node dissection for staging.
Male infertility
Male infertility and trends in semen quality.
Key point: Male infertility management should be couple-centered, integrating the female partner's reproductive timeline to avoid preventable delays in effective therapy.
Robotic partial nephrectomy
Robot-assisted partial nephrectomy for kidney tumours.
Focal therapy for prostate cancer
Treating only the tumour area within the prostate.
Beta-3 agonists for overactive bladder
Mirabegron and vibegron for overactive bladder.
Key point: Vibegron appears to rank more favourably for urgency, urgency incontinence and maximum voided volume, while mirabegron ranks more favourably for 24-hour frequency.
BCG-unresponsive bladder cancer
New options for non-muscle invasive bladder cancer after BCG fails.
Too many papers to read?
PubDaily picks the ones that matter in your specialty and summarises them, about 10 minutes a week.
How these numbers are counted
PubMed query, searched in titles and abstracts by publication date:
"recurrent urinary tract infection*"[tiab] AND (prevent*[tiab] OR vaccin*[tiab] OR prophylaxis[tiab])Trials: ClinicalTrials.gov studies first submitted in each 12-month window that match the same terms. A query can miss synonyms or catch unrelated papers, so treat counts as approximate.